Labcorp Holdings Inc. (LH) Revenue CAGR:7.34%(TTM)
Revenue CAGR uses precomputed financial statement history.
Over longer horizons, Labcorp Holdings Inc.'s Revenue CAGR averages 4.20% over 3 years and -1.58% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how Labcorp Holdings Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
LH Revenue CAGR Chart
Labcorp Holdings Inc. (LH)
LH Quarterly Revenue Growth (YoY)
Revenue growth vs the same quarter one year earlier, last 20 quarters.
LH Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $13.01B | $13.95B | +$942.80M | +7.25% | +7.25% |
| 2024 | $12.16B | $13.01B | +$847.30M | +6.97% | +6.97% |
| 2023 | $11.86B | $12.16B | +$297.70M | +2.51% | +2.51% |
| 2022 | $13.14B | $11.86B | $-1.27B | -9.68% | -9.68% |
| 2021 | $13.98B | $13.14B | $-842.40M | -6.03% | -6.03% |
| 2020 | $11.55B | $13.98B | +$2.42B | +20.98% | +20.98% |
| 2019 | $11.33B | $11.55B | +$221.40M | +1.95% | +1.95% |
| 2018 | $10.44B | $11.33B | +$892.00M | +8.54% | +8.54% |
| 2017 | $9.64B | $10.44B | +$799.60M | +8.29% | +8.29% |
| 2016 | $8.68B | $9.64B | +$961.70M | +11.08% | +11.08% |
| 2015 | $6.01B | $8.68B | +$2.67B | +44.39% | +44.39% |
| 2014 | $5.81B | $6.01B | +$203.30M | +3.50% | +3.50% |
| 2013 | $5.67B | $5.81B | +$136.90M | +2.41% | +2.41% |
| 2012 | $5.54B | $5.67B | +$129.10M | +2.33% | +2.33% |
| 2011 | $5.00B | $5.54B | +$538.40M | +10.76% | +10.76% |
| 2010 | $4.69B | $5.00B | +$309.20M | +6.59% | +6.59% |
| 2009 | $4.51B | $4.69B | +$189.50M | +4.21% | +4.21% |
| 2008 | $4.07B | $4.51B | +$437.00M | +10.74% | +10.74% |
| 2007 | $3.59B | $4.07B | +$477.40M | +13.30% | +13.30% |
| 2006 | $3.33B | $3.59B | +$263.20M | +7.91% | +7.91% |
| 2005 | $3.08B | $3.33B | +$242.80M | +7.87% | +7.87% |
| 2004 | $2.94B | $3.08B | +$145.40M | +4.95% | +4.95% |
| 2003 | $2.51B | $2.94B | +$431.70M | +17.21% | +17.21% |
| 2002 | $2.20B | $2.51B | +$307.90M | +14.00% | +14.00% |
| 2001 | $1.92B | $2.20B | +$280.50M | +14.61% | +14.61% |
| 2000 | $1.70B | $1.92B | +$220.60M | +12.99% | +12.99% |
| 1999 | $1.61B | $1.70B | +$86.10M | +5.34% | +5.34% |
| 1998 | $1.52B | $1.61B | +$93.60M | +6.16% | +6.16% |
| 1997 | $1.61B | $1.52B | $-88.70M | -5.52% | -5.52% |
Quarterly Revenue: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $3.54B | +0.6% | +5.8% |
| Q4 2025 | $3.52B | -1.3% | +5.6% |
| Q3 2025 | $3.56B | +1.0% | +8.6% |
| Q2 2025 | $3.53B | +5.4% | +9.5% |
| Q1 2025 | $3.35B | +0.5% | +5.3% |
| Q4 2024 | $3.33B | +1.4% | +9.8% |
| Q3 2024 | $3.28B | +1.9% | +7.4% |
| Q2 2024 | $3.22B | +1.4% | +6.2% |
| Q1 2024 | $3.18B | +4.7% | +4.6% |
| Q4 2023 | $3.03B | -0.8% | -17.4% |
| Q3 2023 | $3.06B | +0.8% | +6.6% |
| Q2 2023 | $3.03B | -0.1% | +3.8% |
| Q1 2023 | $3.04B | -17.3% | -22.1% |
| Q4 2022 | $3.67B | +28.2% | -9.4% |
| Q3 2022 | $2.87B | -1.9% | -29.4% |
| Q2 2022 | $2.92B | -25.0% | -23.9% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter